Market revenue in 2023 | USD 30.3 million |
Market revenue in 2030 | USD 43.8 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.83% in 2023. Horizon Databook has segmented the Egypt intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
Egypt is a promising emerging economy with lucrative healthcare markets and a large young population, according to the Egyptian Minister of Planning and Economic Development. Cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases are currently the leading causes of death in Egypt, accounting for 82% of all deaths in the country.
The Egyptian government, in affiliation with WHO, has opened 19 primary healthcare centers for diagnosis and treatments for these diseases to tackle the burden. The number of cancer patients is on the rise, with 108,600 new cases of cancer diagnosed in 2018.
The Central Administration for Pharmaceutical Affairs (CAPA) monitors the use of medical devices in the country. The rise in disease burden and supportive government reforms are likely to propel the infusion pumps market in Egypt.
Horizon Databook provides a detailed overview of country-level data and insights on the Egypt intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into Egypt intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account